Rheumatology Doctors in Jackson, MS Accepting Medicare

12 Rheumatology doctors found. Showing 1 - 12

Dr. Vikas Majithia, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2500 North State Street, Department Of Medicine/division Of Rheumatology, Jackson, MS 39216 Phone: 601-984-5540

Cathy Patricia Lee Ching, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-2005

Dr. Amanda Horne Fowler, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Dept. Of Medicine, Jackson, MS 39216 Phone: 601-984-5601    Fax: 601-984-6665

Dr. James G. Wilson, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Department Of Medicine/division Of Rheumatology, Jackson, MS 39216 Phone: 601-984-5540

Neal Ira Shparago, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273    Fax: 601-714-3415

Nirupa Mohandas, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1190 N State St Ste 303, Jackson, MS 39202 Phone: 601-360-1106    Fax: 601-360-1713

Dr. Maneesh Mannem, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5540

Linda R Rockhold, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 971 Lakeland Drive, Suite 1157, Jackson, MS 39216 Phone: 601-362-6900    Fax: 601-362-6111

Dr. Suzanne Sanders, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 1500 E Woodrow Wilson Ave, Jackson, MS 39216 Phone: 601-362-4471    Fax: 601-364-1327

Dr. Robert W. Mcmurray Jr., MD Internal Medicine - Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 2500 North State Street, Department Of Medicine/division Of Rheumatology, Jackson, MS 39216 Phone: 601-984-5540

Clara Ann Myers, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 971 Lakeland Drive, Suite 1157, Jackson, MS 39216 Phone: 601-362-6900    Fax: 601-362-6111

Dannette Smith Johnson, D.O. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 2500 North State Street, Department Of Medicine Division Of Rheumatology, Jackson, MS 39216 Phone: 601-984-5540

News Archive

Halt Medical's Tulip RFVTA probe granted Canadian approval for treatment of uterine fibroids

Halt Medical, Inc. announced today that it has been approved to market the Tulip™ Radiofrequency Volumetric Thermal Ablation (RFVTA) probe in Canada. "The license we just received from Health Canada brings us an important step closer to our goal of making our uterine sparing procedure available to the millions of women in North America who suffer with uterine fibroids", said Russ DeLonzor, President and COO of Halt Medical.

Researchers encourage PCPs to screen for OSA in patients with Type 2 diabetes

Researchers in New Jersey are encouraging primary care physicians to screen for obstructive sleep apnea (OSA) in patients with Type 2 diabetes. They found that in a small sample of clinic patients, the risk for sleep apnea was high among diabetics compared with non-diabetics, and that sleep apnea appeared to be associated with carbohydrate craving.

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Sangamo BioSciences, Inc. announced today the presentation of preliminary data from the Phase 2 clinical trial of its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for amyotrophic lateral sclerosis (ALS) at a Work in Progress session at the 20th International Symposium on ALS/MND held in Berlin, Germany.

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

PPD, Inc. today announced it has entered an agreement with Janssen Pharmaceutica N.V. to develop and commercialize two Phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome (IBS-d) and the other to treat complicated skin and skin structure and respiratory infections.

Read more Medical News

› Verified 1 days ago